Olaf De Jager

Olaf De Jager is the Cerba Research Legal Counsel. He joined Cerba Research as part of the merger with Viroclinics. Olaf joined Viroclinics at the end of 2006. With a background as an attorney at law and as legal counsel with the Technology Transfer Office of the Erasmus University Medical Center Rotterdam, the Netherlands, Olaf has acquired extensive experience drafting, negotiating, and managing contracts in the biotechnology sector. Olaf studied tax law at the University of Tilburg, the Netherlands, and graduated in 1998. He subsequently went on to obtain an LL.M in international law from the University of Minnesota, USA, after which he joined the Dutch law firm AKD in 2001 working in its intellectual property law section. Olaf completed his professional training as an attorney at law in 2004.

In 2004 Olaf moved to the Erasmus MC to work as legal counsel for its technology Transfer Office. In this position he assisted with the start-ups of several spin-out companies of the Erasmus MC, including Viroclinics Biosciences B.V.

In 2006 Olaf left the Erasmus MC Technology Transfer Office and started as legal counsel for three Erasmus MC spin-outs, ViroNovative B.V. and Viroclinics B.V.. In 2011 Olaf joined Viroclinics’ management team full-time as Director Legal.

Back to Team